Developing a placebo-controlled trial in surgery: issues of design, acceptability and feasibility

M K Campbell, V A Entwistle, B H Cuthbertson, Z C Skea, A G Sutherland, A M McDonald, J D Norrie, R V Carlson, S Bridgman, KORAL study group, Seonaidh Cotton, Angela Donaldson, Ray Fitzpatrick, Adrian Grant, Alastair Gray, James Hutchison, Marie Johnston, David Murray, Craig Ramsay, David Rowley, Luke Vale, Carlos Wigderowitz, M K Campbell, V A Entwistle, B H Cuthbertson, Z C Skea, A G Sutherland, A M McDonald, J D Norrie, R V Carlson, S Bridgman, KORAL study group, Seonaidh Cotton, Angela Donaldson, Ray Fitzpatrick, Adrian Grant, Alastair Gray, James Hutchison, Marie Johnston, David Murray, Craig Ramsay, David Rowley, Luke Vale, Carlos Wigderowitz

Abstract

Background: Surgical placebos are controversial. This in-depth study explored the design, acceptability, and feasibility issues relevant to designing a surgical placebo-controlled trial for the evaluation of the clinical and cost effectiveness of arthroscopic lavage for the management of people with osteoarthritis of the knee in the UK.

Methods: Two surgeon focus groups at a UK national meeting for orthopaedic surgeons and one regional surgeon focus group (41 surgeons); plenary discussion at a UK national meeting for orthopaedic anaesthetists (130 anaesthetists); three focus groups with anaesthetists (one national, two regional; 58 anaesthetists); two focus groups with members of the patient organisation Arthritis Care (7 participants); telephone interviews with people on consultant waiting lists from two UK regional centres (15 participants); interviews with Chairs of UK ethics committees (6 individuals); postal surveys of members of the British Association of Surgeons of the Knee (382 surgeons) and members of the British Society of Orthopaedic Anaesthetists (398 anaesthetists); two centre pilot (49 patients assessed).

Results: There was widespread acceptance that evaluation of arthroscopic lavage had to be conducted with a placebo control if scientific rigour was not to be compromised. The choice of placebo surgical procedure (three small incisions) proved easier than the method of anaesthesia (general anaesthesia). General anaesthesia, while an excellent mimic, was more intrusive and raised concerns among some stakeholders and caused extensive discussion with local decision-makers when seeking formal approval for the pilot.Patients were willing to participate in a pilot with a placebo arm; although some patients when allocated to surgery became apprehensive about the possibility of receiving placebo, and withdrew. Placebo surgery was undertaken successfully.

Conclusions: Our study illustrated the opposing and often strongly held opinions about surgical placebos, the ethical issues underpinning this controversy, and the challenges that exist even when ethics committee approval has been granted. It showed that a placebo-controlled trial could be conducted in principle, albeit with difficulty. It also highlighted that not only does a placebo-controlled trial in surgery have to be ethically and scientifically acceptable but that it also must be a feasible course of action. The place of placebo-controlled surgical trials more generally is likely to be limited and require specific circumstances to be met. Suggested criteria are presented.

Trial registration number: The trial was assigned ISRCTN02328576 through http://controlled-trials.com/ in June 2006. The first patient was randomised to the pilot in July 2007.

Figures

Figure 1
Figure 1
Schematic of pilot.
Figure 2
Figure 2
Feasibility checklist for surgical placebo controlled trials.

References

    1. Cobb LA, Thomas GI, Dillard DH, Merendino KA, Bruce RA. An evaluation of internal-mammary-artery ligation by a double-blind technic. N Engl J Med. 1959;260:1115–8. doi: 10.1056/NEJM195905282602204.
    1. Freeman CPL, Basson JV, Crighton A. Double-blind controlled trial of electroconvulsive therapy (ECT) and simulated ECT in depressive illness. Lancet. 1978;1:738–40. doi: 10.1016/S0140-6736(78)90857-7.
    1. Lambourn J, Gill D. A controlled comparison of simulated and real ECT. Br J Psychiat. 1978;133:514–19. doi: 10.1192/bjp.133.6.514.
    1. Johnstone EC, Deakin JFW, Lawler P, Frith CD, Stevens M, McPherson K, Crow TJ. The Northwick Park electroconvulsive therapy trial. Lancet. 1980;2:1317–20. doi: 10.1016/S0140-6736(80)92393-4.
    1. West ED. Electric convulsion therapy in depression: a double blind controlled trial. BMJ. 1981;282:355–7. doi: 10.1136/bmj.282.6261.355.
    1. Gregory S, Shawcross CR, Gill D. The Nottingham ECT study: a double-blind comparison of bilateral, unilateral and simulated ECT in depressive illness. Br J Psychiat. 1985;146:520–4. doi: 10.1192/bjp.146.5.520.
    1. Freed CR, Greene PE, Breeze RE, Tsai W-Y, DuMouchel W, Kao R, Dillon S, Winfield H, Culver S, Trojanowski JQ, Eidelberg D, Fahn S. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med. 2001;344(10):710–9. doi: 10.1056/NEJM200103083441002.
    1. Freeman TB, Vawter DE, Leaverton PE, Godbold JH, Hauser RA, Goetz CG, Olanow CW. Use of placebo-surgery in controlled trials of cellular-based therapy for Parkinson's disease. New Engl J Med. 1999;341(13):988–92. doi: 10.1056/NEJM199909233411311.
    1. Wolf B, Buckwalter JA. Randomized surgical trials and "sham" surgery: relevance to modern orthopaedics and minimally invasive surgery. Iowa Orthop J. 2006;26:107–11.
    1. Macklin R. The ethical problems of sham surgery in clinical research. N Engl J Med. 1999;341:992–6. doi: 10.1056/NEJM199909233411312.
    1. London AJ, Kadane JB. Placebos that harm: sham surgery controls in clinical trials. Stat Methods Med Res. 2002;11:413–27. doi: 10.1191/0962280202sm300ra.
    1. Shapiro AK. Factors contributing to the placebo effect. Their implications for psychotherapy. Am J Psychother. 1964;18:73–88.
    1. Brody H. Placebos and the philosophy of medicine. Clinical, conceptual and ethical issues. Chicago: University of Chicago Press; 1980.
    1. De Craen AJM, Kaptchuk TJ, Tijssen JGP, Kleijnen J. Placebos and placebo effects in medicine: historical overview. J Roy Soc Med. 1999;92:511–5.
    1. Campbell MK, Skea ZC, Sutherland AG, Cuthbertson BH, Entwistle VA, McDonald AM, Norrie JD, Carlson R, Bridgman S. for the KORAL study group. The effectiveness and cost-effectiveness of arthroscopic lavage in the treatment of osteoarthritis of the knee: a mixed methods study of the feasibility of conducting a surgical placebo-controlled trial (the KORAL study) Health Technology Assessment. 2010;14:5.
    1. Moseley JB, O'Malley K, Petersen NJ, Menke TJ, Brody B, Kuykendall DH, Hollingsworth JC, Ashton CM, Wray NP. A controlled trial of arthroscopic surgery for osteoarthritis of the knee. New Engl J Med. 2002;347:81–8. doi: 10.1056/NEJMoa013259.
    1. Fowler P. Commentary. J Bone Joint Surg Am. 2003;85:387.
    1. Johnson LL. A controlled trial of arthroscopic surgery for osteoarthritis of the knee [letter] Arthroscopy. 2002;18(7):683–686. doi: 10.1053/jars.2002.36247.
    1. Chambers K, Schulzer M, Sobolev B. A controlled trial of arthroscopic surgery for osteoarthritis of the knee [letter] Arthroscopy. 2002;18:686–7.
    1. Ritchie J, Spencer L. In: Analysing Qualitative Data. Bryman A, Burgess RG, editor. London: Routledge; 1994. Qualitative data analysis for applied policy research.
    1. Saklad M. Grading of patients for surgical procedures. Anesthesiology. 1941;2:281–4. doi: 10.1097/00000542-194105000-00004.
    1. American Society of Anaesthesiology: ASA Physical Status Classification system. [cited 7 January 2011].
    1. HESonline Hospital Episode Statistics: Total procedures and interventions. [database on the Internet] NHS Information Centre, 2005-08. [cited 30 September 2008].
    1. Emmanuel EJ, Wendler D, Grady C. What makes clinical research ethical? JAMA. 2000;283:2701–11. doi: 10.1001/jama.283.20.2701.
    1. Horng S, Miller FG. Is placebo surgery unethical? New Engl J Med. 2002;347:137–139. doi: 10.1056/NEJMsb021025.
    1. Wood L, Egger M, Gluud LL, Schulz KF, Juni P, Altman DG, Gluud C, Martin RM, Wood AJG, Sterne JAC. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ. 2008;336:601–5. doi: 10.1136/.
    1. Edwards SJL, Stevens AJ, Braunholtz DA, Lilford RJ, Swift T. The ethics of placebo-controlled trials: a comparison of inert and active placebo controls. World J Surg. 2005;29(5):610–4. doi: 10.1007/s00268-005-7621-7.
    1. Ramsay CR, Grant AM, Wallace SA, Garthwaite PH, Monk AF, Russell IT. Statistical assessment of the learning curves of health technologies. Health Technol Assess. 2001;5(12):1–79.
    1. American Medical Association. Council on Ethical and Judicial Affairs. Code of medical ethics: current opinions with annotations: 2002-2003. Chicago: American Medical Association; 2002. Surgical placebo controls.
    1. McLeod RS. Issues in surgical randomized controlled trials. World J Surg. 1999;23:1210–4. doi: 10.1007/s002689900649.
    1. Ergina PL, Cook JA, Blazeby JM, Boutron I, Calvien PA, Reeves BC, Seiler CM. for the Balliol Collaboration. Challenges in evaluating surgical innovation. Lancet. 2009;374:1097–104. doi: 10.1016/S0140-6736(09)61086-2.
    1. Murphy E, Spiegal N, Kinmonth AL. "Will you help me with my research?" Gaining access to primary care settings and subjects. Brit J Gen Pract. 1992;42(357):162–5.
    1. Walker A, Campbell MK, Grimshaw JM. the TEMPEST group. A recruitment strategy for cluster randomised trials in secondary care settings. J Eval Clin Pract. 2000;6:185–92. doi: 10.1046/j.1365-2753.2000.00235.x.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa